Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial
Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference3%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check57 days agoChange DetectedThe page has undergone a version update from v2.14.4 to v2.15.0, and the mention of Principal Investigator Karen K Miller, MD from Massachusetts General Hospital has been removed.SummaryDifference1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check114 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.